MATERIAL SAFETY DATA SHEET Pharmacal Research Laboratories Inc. 33 Great Hill Road Naugatuck, CT 06770 (203) 729-5237 800-243-5350 FAX (203) 729-5230
NFPA HMIS NOT ESTABLISHED NOT ESTABLISHED
DATE OF ISSUE-5/25/00
I. IDENTIFICATION AND EMERGENCY INFORMATION
PRODUCT NAME: CLIDOX-S® DILUTION (1:5:1 & 1:18:1)
PRODUCT CODE: N/A
CHEMICAL NAME: CHLORINE DIOXIDE LIQUID
CAS NUMBER: N/A
PRODUCT APPEARANCE AND ODOR: LIGHT YELLOW COLORED LIQUID - SLIGHT CHLORINE ODOR
EMERGENCY TELEPHONE NUMBERS: FOR CHEMICAL EMERGENCY CHEMTREC 1-800-424-9300 IN DISTRICT OF COLUMBIA COLLECT 483-7616 OUTSIDE THE CONTINENTAL U.S. COLLECT (202) 483-7616
II. COMPONENTS AND HAZARD INFORMATION
COMPONENTS CAS NO. OF APPROXIMATE COMPONENTS CONCENTRATION MIXTURE OF BASE + WATER +ACTIVATOR
III. EMERGENCY AND FIRST AID PROCEDURES
EYE CONTACT FLUSH WITH WATER FOR AT LEAST 15 MINUTES- CONTACT PHYSICIAN
SKIN CONTACT WASH WITH WATER FOR AT LEAST 15 MINUTES- REMOVE CONTAMINATED CLOTHING
INHALATION MOVE TO FRESH AIR. CONSULT A PHYSICIAN IF IRRITATION OF RESPIRATORY PASSAGES OCCUR
INGESTION DO NOT INDUCE VOMITING! DRINK LARGE QUANTITIES OF WATER. SEEK MEDICAL ATTENTION. DO NOT GIVE ANYTHING BY MOUTH IF THE PERSON IS UNCONSCIOUS OR HAVING SEIZURES. IV. FIRE AND EXPLOSION DATA
HANDLING PRECAUTIONS: STORE AWAY FROM HEAT AND ACIDS
EXTINGUISHING MEDIA AND FIRE SELF CONTAINED BREATHING FIGHTING PROCEDURES: APPARATUS - WATER AS MEDIA
DECOMPOSITION PRODUCTS UNDER FIRE CHLORINE - CHLORINE DIOXIDE CONDITIONS:
“EMPTY” CONTAINER WARNINGS RINSE THOROUGHLY WITH WATER - CLIDOX-S® DILUTION (1:5:1 & 1:18:1) PAGE 1 OF 4 MATERIAL SAFETY DATA SHEET Pharmacal Research Laboratories Inc. 33 Great Hill Road Naugatuck, CT 06770 (203) 729-5237 800-243-5350 FAX (203) 729-5230
DISPOSE OF CONTAINER IN CONFORMANCE WITH FEDERAL, STATE AND LOCAL REGULATIONS
V. HEALTH AND HAZARD INFORMATION
VARIABILITY AMONG INDIVIDUALS: NONE KNOWN
EFFECTS OF OVEREXPOSURE: PERSISTENT EYE AND MUCOUS IRRITANT (SIGNS AND SYMPTOMS OF EXPOSURE)
NATURE OF HAZARD AND TOXICITY INFORMATION:
ACUTE ORAL TOXICITY MATERIAL IS CONSIDERED NON-TOXIC
PRIMARY SKIN IRRITATION NONE
EYE IRRITATION MINOR EYE IRRITANT
VI. PHYSICAL DATA THE FOLLOWING DATA ARE APPROXIMATE OR TYPICAL VALUES AND SHOULD NOT BE USED FOR PRECISE DESIGN PURPOSES. BOILING POINT 100°C pH 3
EVAPORATION RATE @ 1 ATM AND 25C SIMILAR TO WATER SOLUBILITY IN WATER @ 1 ATM AND 25C COMPLETE
VII. REACTIVITY
AVOID HEAT - TEMPERATURES ABOVE 100°F SHOULD BE AVOIDED
AVOID STRONG ALKALI (BASES)
VIII. SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED: FLUSH WITH WATER TO DRAIN IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL REGULATIONS
IX. PROTECTION AND PRECAUTIONS
VENTILATION: LOCAL EXHAUST RESPIRATORY PROTECTION: FOR EXCESSIVE EXPOSURE USE NIOSH APPROVED RESPIRATOR SUITABLE FOR
CLIDOX-S® DILUTION (1:5:1 & 1:18:1) PAGE 2 OF 4 MATERIAL SAFETY DATA SHEET Pharmacal Research Laboratories Inc. 33 Great Hill Road Naugatuck, CT 06770 (203) 729-5237 800-243-5350 FAX (203) 729-5230
CHLORINE PROTECTIVE GLOVES: CHEMICAL RESISTANT RUBBER OR LATEX GLOVES EYE PROTECTION: CHEMICAL SAFETY GOGGLES OTHER PROTECTIVE EQUIPMENT: APRON- SOLUTION MAY STAIN CLOTHING WORK PRACTICES / SEE SECTION VII ENGINEERING CONTROL: PERSONAL HYGIENE: WASH AFTER HANDLING - CLEAN CONTAMINATED GARMENTS BEFORE REUSING
X. TRANSPORTATION INFORMATION
TRANSPORTATION INCIDENT NOT TRANSPORTED IN THIS FORM INFORMATION:
DOT IDENTIFICATION NUMBER N/A
SHIPPING DESCRIPTION NOT TRANSPORTED IN THIS FORM
THE INFORMATION AND RECOMMENDATIONS CONTAINED HEREIN ARE, TO THE BEST OF PHARMACAL’S KNOWLEDGE AND BELIEF, ACCURATE AND RELIABLE AS OF THE DATE ISSUED. PHARMACAL DOES NOT WARRANT OR GUARANTEE THEIR ACCURACY OR RELIABILITY, AND PHARMACAL SHALL NOT BE LIABLE FOR ANY LOSS OR DAMAGE ARISING OUT OF THERE USE THEREOF.
THE INFORMATION AND RECOMMENDATIONS ARE OFFERED FOR THE USER’S CONSIDERATION AND EXAMINATION, AND IT IS THE USER’S RESPONSIBILITY TO SATISFY ITSELF THAT THEY ARE SUITABLE AND COMPLETE FOR ITS PARTICULAR USE.
THE HAZARDOUS MATERIALS IDENTIFICATION SYSTEM (HMIS) AND NATIONAL FIRE PROTECTION ASSOCIATION RATINGS HAVE BEEN INCLUDED BY PHARMACAL RESEARCH LABORATORIES INC. IN ORDER TO PROVIDE ADDITIONAL HEALTH AND HAZARD INFORMATION. THE RATINGS RECOMMENDED ARE BASED UPON CRITERIA SUPPLIED BY THE DEVELOPERS OF THESE RATING SYSTEMS, TOGETHER WITH PHARMACAL’S INTERPRETATION OF THE AVAILABLE DATA.
CLIDOX-S® DILUTION (1:5:1 & 1:18:1) PAGE 3 OF 4